SAPONARO, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 3.522
EU - Europa 2.981
AS - Asia 1.398
SA - Sud America 292
AF - Africa 37
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.236
Nazione #
US - Stati Uniti d'America 3.455
FI - Finlandia 1.929
SG - Singapore 422
CN - Cina 394
DE - Germania 247
BR - Brasile 237
IT - Italia 212
VN - Vietnam 204
PL - Polonia 162
HK - Hong Kong 108
TR - Turchia 101
GB - Regno Unito 86
UA - Ucraina 86
SE - Svezia 63
RU - Federazione Russa 55
FR - Francia 48
CA - Canada 41
IN - India 40
BD - Bangladesh 27
JP - Giappone 22
AR - Argentina 21
BE - Belgio 21
ZA - Sudafrica 21
MX - Messico 19
ID - Indonesia 17
IQ - Iraq 16
ES - Italia 15
NL - Olanda 15
CO - Colombia 10
AT - Austria 9
EC - Ecuador 8
CZ - Repubblica Ceca 7
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
UY - Uruguay 5
AU - Australia 4
CL - Cile 4
KR - Corea 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
PH - Filippine 2
PY - Paraguay 2
TH - Thailandia 2
VE - Venezuela 2
AL - Albania 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TT - Trinidad e Tobago 1
Totale 8.236
Città #
Helsinki 1.884
Dallas 747
Ashburn 354
Singapore 285
Fairfield 279
Woodbridge 268
Warsaw 160
San Jose 151
Houston 139
Ann Arbor 135
Beijing 130
Wilmington 117
Chandler 112
Santa Clara 105
Hong Kong 103
Jacksonville 102
Seattle 102
Cambridge 91
Ferrara 86
Munich 67
New York 54
Los Angeles 50
Ho Chi Minh City 48
Hanoi 47
Izmir 38
Shanghai 33
Nanjing 32
Dong Ket 28
Milan 25
Boardman 24
Princeton 24
São Paulo 23
Turku 23
Brussels 21
Lauterbourg 21
Tokyo 20
Orem 18
Council Bluffs 17
San Diego 17
Montreal 13
Buffalo 12
Shenyang 12
Amsterdam 11
Frankfurt am Main 11
Baghdad 10
Chicago 10
Stockholm 10
Toronto 10
Changsha 9
London 9
Atlanta 8
Brasília 8
Da Nang 8
Hebei 8
Jiaxing 8
Mexico City 8
Mumbai 8
Phoenix 8
Redwood City 8
Tianjin 8
Addison 7
Ankara 7
Bremen 7
Brooklyn 7
Denver 7
Guangzhou 7
Haiphong 7
Johannesburg 7
Mcallen 7
Poplar 7
Des Moines 6
Hefei 6
Hải Dương 6
Jakarta 6
Montréal 6
Nanchang 6
Rome 6
Auburn Hills 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Chennai 5
Curitiba 5
Falls Church 5
Montevideo 5
Moscow 5
Querétaro 5
San Mateo 5
Tashkent 5
Thái Nguyên 5
Zhengzhou 5
Bari 4
Boston 4
Cagliari 4
Guarulhos 4
Istanbul 4
Jinan 4
Manchester 4
Mountain View 4
Rio de Janeiro 4
Totale 6.395
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.095
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists 316
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 299
A3 adenosine receptor antagonists: History and future perspectives 286
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 277
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 262
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 253
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 246
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 242
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 228
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 225
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 211
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 203
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 202
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 157
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy 145
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 138
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 130
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 128
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 125
null 124
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 123
null 121
null 118
null 107
null 103
null 96
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 94
null 84
null 83
Transient receptor potential ankyrin 1 (TRPA1) antagonists 70
Totale 8.291
Categoria #
all - tutte 23.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.054
Totale 24.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022321 20 17 31 15 28 18 15 15 22 33 23 84
2022/2023286 29 37 4 39 37 40 22 16 37 1 12 12
2023/2024216 17 16 8 5 22 42 6 33 2 6 5 54
2024/2025773 23 42 63 39 72 77 53 47 95 46 109 107
2025/20264.524 211 261 708 256 304 154 208 101 2.016 195 90 20
Totale 8.291